尼莫利祖马布在皮炎患者中的不成比例性分析:现实世界药监测研究
Maohua Chen1, Chengjie Ke2,3, Yaping Huang4
1From the Department of Pharmacy, Pingtan Comprehensive Experimental Area Hospital, Fuzhou, China.
Dermatitis : contact, atopic, occupational, drug
|November 18, 2025
概括
这项研究分析了现实世界的数据,以评估纳莫利祖马布对亚托皮炎的安全性. 它确定了常见的副作用和罕见但严重的事件,包括新的安全信号,如睡眠障碍.
科学领域:
- 皮肤病学 皮肤病学
- 药物监督 药物监督 药物监督
- 临床研究 临床研究
背景情况:
- 尼莫利祖马布已批准用于12岁及以上患者的中度至重度亚托皮炎.
- 目前关于尼莫利祖马布长期安全性的数据有限,需要进一步调查.
研究的目的:
- 通过使用现实世界的数据来评估尼莫利祖马布的长期安全性.
- 为了识别与尼莫利祖马布治疗相关的不良事件信号.
主要方法:
- 使用四个算法 (ROR,PRR,IC,EBGM) 的不成比例分析.
- 数据来源于2024年第一季度至2025年第二季度的FDA不良事件报告系统 (FAERS).
主要成果:
- 最常见的不良事件包括,皮疹和头痛.
- 鉴定到的最重要的AE信号是疹疹,皮,和皮肤炎脱皮性一般化.
- 发现了新的副作用,如睡眠障碍和氨基酸细胞数量升高,以及注射部位反应和疹.
结论:
- 这项研究提供了Nemolizumab.com的全面现实安全概述.
- 这些发现突出了预期和新出现的风险,为临床监测和风险管理策略提供了信息.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
139
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
139
Bioequivalence studies: Biowaivers
210
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
210
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
387
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
387
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659


